McKenzie, S. C. and Rahman, A. Bradycardia in a patient taking black cohosh. Med J Aust. 10-18-2010;193(8):479-481. View abstract.
Naser, B. and Liske, E. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust. 1-19-2009;190(2):99. View abstract.
Nash LI, Desindes S. Canadian consensus conference on menopause 2006 update. J Obstet Gynaecol Can 2006;28:S69-74.
Nedrow, A., Miller, J., Walker, M., Nygren, P., Huffman, L. H., and Nelson, H. D. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern.Med 7-24-2006;166(14):1453-1465. View abstract.
Nesselhut T, Schellhase C, Dietrich R, and et al. [Investigations into the growth-inhibitive efficacy of phytopharmacopia with estrogen-like influences on mammary gland carcinoma cells] (translated from German). Arch Gynecol Obstet 1993;254:817-818.
Newton, K. M., Reed, S. D., LaCroix, A. Z., Grothaus, L. C., Ehrlich, K., and Guiltinan, J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 12-19-2006;145(12):869-879. View abstract.
Ng, S. S. and Figg, W. D. Antitumor activity of herbal supplements in human prostate cancer xenografts implanted in immunodeficient mice. Anticancer Res 2003;23(5A):3585-3590. View abstract.
Nisslein, T. and Freudenstein, J. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner.Metab 2003;21(6):370-376. View abstract.
Noguchi, M., Nagai, M., Koeda, M., Nakayama, S., Sakurai, N., Takahira, M., and Kusano, G. Vasoactive effects of cimicifugic acids C and D, and fukinolic acid in cimicifuga rhizome. Biol Pharm Bull 1998;21(11):1163-1168. View abstract.
Nuntanakorn, P., Jiang, B., Einbond, L. S., Yang, H., Kronenberg, F., Weinstein, I. B., and Kennelly, E. J. Polyphenolic constituents of Actaea racemosa. J Nat Prod 2006;69(3):314-318. View abstract.
Nuntanakorn, P., Jiang, B., Yang, H., Cervantes-Cervantes, M., Kronenberg, F., and Kennelly, E. J. Analysis of polyphenolic compounds and radical scavenging activity of four American Actaea species. Phytochem.Anal. 2007;18(3):219-228. View abstract.
Onorato, J. and Henion, J. D. Evaluation of triterpene glycoside estrogenic activity using LC/MS and immunoaffinity extraction. Anal.Chem 10-1-2001;73(19):4704-4710. View abstract.
Australian Adverse Drug Reactions Advisory Committee. Black cohosh and liver toxicity - an update. Aust Adv Drug Reactions Bull 2007;26:11.
Bolman WM, Richmond JA. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. J Autism Dev Disord 1999;29:191-4. View abstract.
Freed WJ. N,N-dimethylglycine, betaine and seizures [letter]. Arch Neurol 1984;41:1129-30. View abstract.
Freed WJ. Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine. Pharmacol Biochem Behav 1985;22:641-3. View abstract.
Gascon G, Patterson B, Yearwood K, Slotnick H. N,N-dimethylglycine and epilepsy. Epilepsia 1989;30:90-3. View abstract.
Graber CD, Goust JM, Glassman AD, et al. Immunomodulating properties of dimethylglycine in humans. J Infect Dis 1981;143:101-5. View abstract.
Herbert V. N,N-dimethylglycine for epilepsy [letter]. N Engl J Med 1983;308:527-8.
Hoorn AJ. Dimethylglycine and chemically related amines tested for mutagenicity under potential nitrosation conditions. Mutat Res 1989;222:343-50. View abstract.
Reap EA, Lawson JW. Stimulation of the immune response by dimethylglycine, a nontoxic metabolite. J Lab Clin Med 1990;115:481-6. View abstract.
Roach ES, Carlin L. N,N dimethylglycine for epilepsy [letter]. N Engl J Med 1982;307:1081-2.
Ward TN, Smith EB, Reeves AG. Dimethylglycine and reduction of mortality in penicillin-induced seizures [letter]. Ann Neurol 1985;17:213.
Weiss RC. Immunologic responses in healthy random-source cats fed N,N-dimethylglycine-supplemented diets. Am J Vet Res 1992;53:829-33. View abstract.
Wolfsegger T, Böck K, Schimetta W, von Oertzen TJ, Assar H. N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial. Neurol Res Pract 2021;3(1):29. View abstract.